Category leading RWE platform generating differentiated data through combination of a provider community and patient-reported outcomes; delivering personalized and comparative evidence at the point of care
Singular network architecture and data capturing capabilities help identify patients with unmet needs in real-time; unlocking opportunities to improve health outcomes and additional revenue for pharma
Microhealth has achieved product-market fit in the hemophilia and rare blood disorders space
Today, we are the world's leader in digital hematology:
Our US hemophilia network covers 33%+ of patients on prophylaxis and 50%+ of hemophilia treatment centers
Average active-user retention is 52 months
Trusted by leading pharmaceutical sponsors: Novo Nordisk, Sanofi, Roche and Pfizer
